Trump’s Tariffs Set to Hit Ireland, Where Drugmakers Play Tax Games

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a world without President Trump’s tariffs.

News
Kennedy’s New Vaccine Advisers Helped Lawyers Raise Doubts About Their Safety

Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have filed statements in court flagging concerns about vaccines.

News
On a Mission to Heal Gila Monsters

After years in Big Pharma, a chemist pivoted to help save the species that made Ozempic possible.

News
Kennedy Says He Will Give HPV Vaccine Lawsuit Proceeds to His Son

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him of “misconduct or inappropriate behavior.”

News
Kennedy Says He Will Give HPV Vaccine Lawsuit Proceeds to His Son

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him of “misconduct or inappropriate behavior.”

News
Kennedy Is Keeping His Stake in Vaccine Litigation

If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies that issue key decisions for drug companies.

News
Kennedy Was Paid Over $2 Million for Referrals Against Vaccine Makers

If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies that issue key decisions for drug companies.

News
Kennedy Would Keep Stake in H.P.V. Vaccine Suit if Confirmed

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed.

News
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.

News